Annual Operating Expenses
$33.01 M
-$3.49 M-9.56%
31 December 2023
Summary:
Lineage Cell Therapeutics annual total operating expenses is currently $33.01 million, with the most recent change of -$3.49 million (-9.56%) on 31 December 2023. During the last 3 years, it has risen by +$6.17 million (+23.00%). LCTX annual operating expenses is now -50.91% below its all-time high of $67.24 million, reached on 31 December 2015.LCTX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$7.58 M
+$350.00 K+4.84%
30 September 2024
Summary:
Lineage Cell Therapeutics quarterly total operating expenses is currently $7.58 million, with the most recent change of +$350.00 thousand (+4.84%) on 30 September 2024. Over the past year, it has dropped by -$201.00 thousand (-2.58%). LCTX quarterly operating expenses is now -73.85% below its all-time high of $28.99 million, reached on 31 December 2021.LCTX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LCTX Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.6% | -2.6% |
| 3 y3 years | +23.0% | -5.9% |
| 5 y5 years | -21.6% | -11.1% |
LCTX Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -36.1% | +23.0% | -73.8% | +4.8% |
| 5 y | 5 years | -36.1% | +23.0% | -73.8% | +27.8% |
| alltime | all time | -50.9% | +8151.8% | -73.8% | +870.0% |
Lineage Cell Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $7.58 M(+4.8%) |
| June 2024 | - | $7.23 M(-9.7%) |
| Mar 2024 | - | $8.01 M(-2.3%) |
| Dec 2023 | $33.01 M(-9.6%) | $8.19 M(+5.3%) |
| Sept 2023 | - | $7.78 M(-4.2%) |
| June 2023 | - | $8.12 M(-8.8%) |
| Mar 2023 | - | $8.91 M(+5.4%) |
| Dec 2022 | $36.49 M(-29.4%) | $8.45 M(+5.5%) |
| Sept 2022 | - | $8.01 M(-6.5%) |
| June 2022 | - | $8.57 M(-25.2%) |
| Mar 2022 | - | $11.46 M(-60.5%) |
| Dec 2021 | $51.68 M(+92.6%) | $28.99 M(+259.7%) |
| Sept 2021 | - | $8.06 M(+9.0%) |
| June 2021 | - | $7.40 M(+2.3%) |
| Mar 2021 | - | $7.23 M(+21.9%) |
| Dec 2020 | $26.84 M(-32.8%) | $5.93 M(-14.8%) |
| Sept 2020 | - | $6.96 M(+8.4%) |
| June 2020 | - | $6.43 M(-14.4%) |
| Mar 2020 | - | $7.51 M(-0.9%) |
| Dec 2019 | $39.94 M(-5.1%) | $7.58 M(-11.1%) |
| Sept 2019 | - | $8.53 M(-22.2%) |
| June 2019 | - | $10.96 M(-14.8%) |
| Mar 2019 | - | $12.87 M(+24.6%) |
| Dec 2018 | $42.11 M(-0.4%) | $10.33 M(-2.4%) |
| Sept 2018 | - | $10.59 M(+9.8%) |
| June 2018 | - | $9.64 M(-17.2%) |
| Mar 2018 | - | $11.65 M(+15.6%) |
| Dec 2017 | $42.28 M(-30.5%) | $10.08 M(+1.6%) |
| Sept 2017 | - | $9.92 M(-7.2%) |
| June 2017 | - | $10.69 M(-7.7%) |
| Mar 2017 | - | $11.58 M(-3.7%) |
| Dec 2016 | $60.86 M(-9.5%) | $12.03 M(+21.7%) |
| Sept 2016 | - | $9.89 M(-33.3%) |
| June 2016 | - | $14.81 M(-38.6%) |
| Mar 2016 | - | $24.12 M(+9.1%) |
| Dec 2015 | $67.24 M(+29.8%) | $22.11 M(+26.2%) |
| Sept 2015 | - | $17.51 M(+26.8%) |
| June 2015 | - | $13.81 M(+0.0%) |
| Mar 2015 | - | $13.80 M(-5.6%) |
| Dec 2014 | $51.79 M(+27.6%) | $14.62 M(+17.5%) |
| Sept 2014 | - | $12.45 M(-6.2%) |
| June 2014 | - | $13.28 M(+15.5%) |
| Mar 2014 | - | $11.50 M(-10.7%) |
| Dec 2013 | $40.59 M(+54.6%) | $12.87 M(+22.0%) |
| Sept 2013 | - | $10.55 M(+24.7%) |
| June 2013 | - | $8.46 M(-3.0%) |
| Mar 2013 | - | $8.72 M(+17.6%) |
| Dec 2012 | $26.26 M(+29.5%) | $7.42 M(+17.0%) |
| Sept 2012 | - | $6.34 M(-0.3%) |
| June 2012 | - | $6.36 M(+3.4%) |
| Mar 2012 | - | $6.15 M(+42.1%) |
| Dec 2011 | $20.27 M(+81.1%) | $4.32 M(-19.6%) |
| Sept 2011 | - | $5.38 M(-6.3%) |
| June 2011 | - | $5.74 M(+18.3%) |
| Mar 2011 | - | $4.85 M(+70.9%) |
| Dec 2010 | $11.20 M(+105.6%) | $2.84 M(-13.3%) |
| Sept 2010 | - | $3.27 M(+9.3%) |
| June 2010 | - | $3.00 M(+43.1%) |
| Mar 2010 | - | $2.09 M(-312.6%) |
| Dec 2009 | $5.45 M(+25.9%) | -$984.50 K(-129.1%) |
| Sept 2009 | - | $3.38 M(+119.6%) |
| June 2009 | - | $1.54 M(+27.5%) |
| Mar 2009 | - | $1.21 M(-3.6%) |
| Dec 2008 | $4.33 M | $1.25 M(-6.5%) |
| Sept 2008 | - | $1.34 M(-1.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2008 | - | $1.36 M(+72.6%) |
| Mar 2008 | - | $788.10 K(+28.0%) |
| Dec 2007 | $2.27 M(-22.1%) | $615.90 K(+59.2%) |
| Sept 2007 | - | $386.80 K(-23.3%) |
| June 2007 | - | $504.50 K(-33.7%) |
| Mar 2007 | - | $761.30 K(-7.2%) |
| Dec 2006 | $2.91 M(-0.3%) | $820.20 K(+35.2%) |
| Sept 2006 | - | $606.50 K(-22.7%) |
| June 2006 | - | $784.40 K(+11.6%) |
| Mar 2006 | - | $702.80 K(+2.7%) |
| Dec 2005 | $2.92 M(+10.0%) | $684.40 K(+6.3%) |
| Sept 2005 | - | $644.10 K(-4.8%) |
| June 2005 | - | $676.40 K(-26.2%) |
| Mar 2005 | - | $916.60 K(+15.8%) |
| Dec 2004 | $2.66 M(+18.3%) | $791.30 K(+35.0%) |
| Sept 2004 | - | $586.30 K(-8.9%) |
| June 2004 | - | $643.30 K(+1.1%) |
| Mar 2004 | - | $636.20 K(+1.5%) |
| Dec 2003 | $2.25 M(-7.2%) | $626.60 K(+34.1%) |
| Sept 2003 | - | $467.20 K(-20.8%) |
| June 2003 | - | $590.20 K(+5.0%) |
| Mar 2003 | - | $562.30 K(-29.0%) |
| Dec 2002 | $2.42 M(-33.6%) | $792.10 K(+96.4%) |
| Sept 2002 | - | $403.40 K(-36.4%) |
| June 2002 | - | $634.10 K(+7.1%) |
| Mar 2002 | - | $592.00 K(+21.9%) |
| Dec 2001 | $3.65 M(-30.1%) | $485.80 K(-49.9%) |
| Sept 2001 | - | $970.50 K(-16.0%) |
| June 2001 | - | $1.16 M(+16.6%) |
| Mar 2001 | - | $990.90 K(-10.9%) |
| Dec 2000 | $5.22 M(-23.9%) | $1.11 M(-14.8%) |
| Sept 2000 | - | $1.30 M(-6.6%) |
| June 2000 | - | $1.40 M(-0.4%) |
| Mar 2000 | - | $1.40 M(-9.8%) |
| Dec 1999 | $6.86 M(+185.7%) | $1.56 M(-35.1%) |
| Sept 1999 | - | $2.40 M(+41.2%) |
| June 1999 | - | $1.70 M(+41.7%) |
| Mar 1999 | - | $1.20 M(-7.7%) |
| Dec 1998 | $2.40 M(-50.0%) | - |
| Sept 1998 | - | $1.30 M(+18.2%) |
| June 1998 | - | $1.10 M(-15.4%) |
| June 1998 | $4.80 M(+45.5%) | - |
| Mar 1998 | - | $1.30 M(0.0%) |
| Dec 1997 | - | $1.30 M(+8.3%) |
| Sept 1997 | - | $1.20 M(0.0%) |
| June 1997 | $3.30 M(+57.1%) | $1.20 M(+100.0%) |
| Mar 1997 | - | $600.00 K(-25.0%) |
| Dec 1996 | - | $800.00 K(+14.3%) |
| Sept 1996 | - | $700.00 K(+133.3%) |
| June 1996 | $2.10 M(-19.2%) | - |
| Sept 1995 | - | $300.00 K(-62.5%) |
| June 1995 | $2.60 M(+52.9%) | $800.00 K(+33.3%) |
| Mar 1995 | - | $600.00 K(-14.3%) |
| Dec 1994 | - | $700.00 K(+40.0%) |
| Sept 1994 | - | $500.00 K(-16.7%) |
| June 1994 | $1.70 M(+112.5%) | $600.00 K(+100.0%) |
| Mar 1994 | - | $300.00 K(+50.0%) |
| Dec 1993 | - | $200.00 K(0.0%) |
| Sept 1993 | - | $200.00 K(0.0%) |
| June 1993 | $800.00 K(+100.0%) | $200.00 K(0.0%) |
| Mar 1993 | - | $200.00 K(0.0%) |
| Dec 1992 | - | $200.00 K(0.0%) |
| Sept 1992 | - | $200.00 K(0.0%) |
| June 1992 | $400.00 K | $200.00 K(+100.0%) |
| Mar 1992 | - | $100.00 K |
FAQ
- What is Lineage Cell Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Lineage Cell Therapeutics?
- What is Lineage Cell Therapeutics annual operating expenses year-on-year change?
- What is Lineage Cell Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Lineage Cell Therapeutics?
- What is Lineage Cell Therapeutics quarterly operating expenses year-on-year change?
What is Lineage Cell Therapeutics annual total operating expenses?
The current annual operating expenses of LCTX is $33.01 M
What is the all time high annual operating expenses for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high annual total operating expenses is $67.24 M
What is Lineage Cell Therapeutics annual operating expenses year-on-year change?
Over the past year, LCTX annual total operating expenses has changed by -$3.49 M (-9.56%)
What is Lineage Cell Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of LCTX is $7.58 M
What is the all time high quarterly operating expenses for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high quarterly total operating expenses is $28.99 M
What is Lineage Cell Therapeutics quarterly operating expenses year-on-year change?
Over the past year, LCTX quarterly total operating expenses has changed by -$201.00 K (-2.58%)